Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Efficacy of Clopidogrel sulfate50mg and Clopidogrel Sulfate 75mg for the Treatment of Cerebral Infarction

NCT00386191 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00386191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00386191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Efficacy of Clopidogrel sulfate50mg and Clopidogrel Sulfate 75mg for the Treatment of Cerebral Infarction
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
December 31, 2008
Enrollment
1,110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction